Episodes 16-30 of 602
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
On the Frontlines of Prostate CancerProstate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
Patient-Centered Insights for Advanced Prostate Cancer Treatment
On the Frontlines of Prostate CancerPatient-Centered Insights for Advanced Prostate Cancer Treatment
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®Exercise in Multiple Myeloma: Balancing Benefits and Safety
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
On the Frontlines of Prostate CancerAdvances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's RoundtableArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
On the Frontlines of Prostate CancermCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
GI InsightsManaging Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Project Oncology®Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Project Oncology®Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Project Oncology®Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Project Oncology®Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
On the Frontlines of Non-Small Cell Lung CancerTargeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Project Oncology®Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Project Oncology®Preventing MGUS/SMM Progression to Multiple Myeloma with Dietary Interventions
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
On the Frontlines of Non-Small Cell Lung CancerTreating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
